Obesity BMI Healthcare

News

Obesity, Rhythm

Rhythm Pharma's Oral Drug For Rare Obesity Shows Promise

Rhythm's bivamelagon cut BMI and hunger scores in Phase 2 trial for hypothalamic obesity, prompting plans to discuss Phase 3 with regulators.

Reuters on MSN · 1d

Rhythm's drug shows promise in study to treat brain damage-related obesity

Rhythm Pharmaceuticals' experimental drug helped patients with a rare form of obesity caused by brain damage cut weight in a small study, the drugmaker said on Monday, sending its shares 24% higher in early trading.

GlobalData on MSN · 1d

Rhythm’s stock climbs on encouraging Phase II obesity drug data

Rhythm Pharmaceuticals is advancing its oral obesity drug bivamelagon to Phase III studies after it significantly reduced body mass index (BMI) in all three doses. The Phase II study (NCT06046443) was investigating the therapy in patients with acquired hypothalamic obesity.

Medscape3d

New Obesity Definition Raises the Number Who Have It

About 1 in 5 classified as overweight based on BMI alone considered to have obesity according to European society definition.

HealthDay on MSN1d

New Framework Reclassifies Nearly 20% of People as Having Obesity

HealthDay News — The European Association for the Study of Obesity (EASO) framework may offer a more sensitive measure of obesity than traditional body mass index (BMI), according to a study published ...

The Daily Star5d

New guidelines help doctors treat obesity in people with heart failure

Obesity and heart failure often go together, making treatment more complicated. Now, health experts have released new ...

Oncology Nurse Advisor1d

Radical Prostatectomy More Complex With Obesity but Oncologic Outcomes Appear Similar

Obesity in itself is not a contraindication to radical prostatectomy, but it remains a risk factor for poor overall survival. Although obesity increases the technical complexity of radical ...

The University of Alabama at Birmingham2d

Uncovering the connection between obesity and kidney stone disease

Understanding the link between obesity, fatty liver disease and kidney stones provides a new perspective on prevention and ...

Medindia8d

Obesity Clinical Trials: Beyond BMI, Upcoming Webinar Hosted by Xtalks

This precision in risk prediction allows for targeted interventions, potentially reducing unnecessary treatments and improving clinical outcomes.

Zuellig Pharma Launches "Obesity is a Disease" Seminar as Part of "Reduce Size, Reduce Disease" Campaign

Zuellig Pharma, a leading healthcare solutions provider in Asia, is organizing the "Obesity is a Disease" seminar as part of ...

10d

Govt to track children for obesity with new metric

The number of overweight and obese adults in India is expected to rise from 180 million in 2021 to an 449 million by 2050.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results